Latest News & Features
Asia
Magic Circle and major US firm among dealmakers who worked on the licensing agreement for a bispecific antibody candidate, marking another significant outbound licensing deal from China’s biopharma sector. 20 January 2026
Americas
An Israeli medical device company’s lawsuit claims Edwards knowingly infringed its heart-valve patent, raising new risks as the giant pursues growth beyond its core market. 19 January 2026
Careers
The team, known for pharmaceutical and biotechnology patent litigation—including Hatch-Waxman and BPCIA disputes—as well as trade secret and licensing matters, joins a rival US firm. 16 January 2026
Europe
A first-of-its-kind project by sister title WIPR aims to highlight the world’s leading in-house intellectual property counsel—and it needs your help. 16 January 2026
Americas
The wearable tech fight continues as Samsung seeks to block US sales of the Finnish brand's product after being sued over its Galaxy Ring. 15 January 2026
Americas
A court has blocked the patent owner's latest attempt to stop a generic rival as it weighs the right way to challenge a new product. 15 January 2026
Europe
Case between AorticLab and Emboline has implications for UPC playbook in terms of requesting security for costs, and conditional counterclaims. 15 January 2026
Careers
A high-profile departure from the USPTO sees a senior appellate expert move into private practice as demand increases in the firm's life sciences IP practice. 14 January 2026
Careers
The US firm has recruited a European patent attorney with three decades of experience to build its patent prosecution offering across the continent. 14 January 2026
Europe
As the drug moves deeper into its post-exclusivity phase, a Nordic decision highlights the value of secondary patents, presumption of validity, and interim relief when a drug's core patents expire. 13 January 2026